Key Takeaways for Synopsys Stock as of July 2026
- 13 Buy ratings and 3 Outperforms against 6 Holds and 1 Underperform on Synopsys stock, with the consensus mean target at $564 sitting 30% above today’s $435.
- TIKR’s mid-case targets Synopsys stock at $792 by October 2030: 82% total return, 15% annualized.
- With EBITDA margins at 42% and Ansys cost synergies only halfway realized, Synopsys stock looks undervalued at $435 as the Street models expansion toward 44% by fiscal Q4 2026.
- Elliott partner Jesse Cohn joined the board June 1 after the activist built a multi-billion-dollar position, and the company has now raised operating margin guidance three consecutive quarters to 41%.
Synopsys Stock Falls 33% From Highs as Q2 Beat Triggers a Third Straight Guidance Raise
Synopsys (SNPS) posted fiscal Q2 revenue of $2.28 billion and normalized EPS of $3.35, beating Street estimates of $2.25 billion and $3.15, then raised full-year guidance for the third consecutive quarter. EBITDA hit $950 million on a 42% margin, down from a 44% seasonal peak in Q1 but up from 38% in the October quarter. The company lifted its FY26 non-GAAP operating margin target by 50 basis points to 41%.
On the Design Automation side, hardware-assisted verification drove the beat with multiple system wins across the ZeBu and HAPS platforms from hyperscalers scaling emulation for increasingly complex AI chip designs.
CEO Sassine Ghazi described the monetization shift ahead on the Q2 earnings call: “The current thinking, and we’re in early exploration with customers, is how do we build from the subscription license that our customer has for the human engineers to run our product to subscription plus consumption for the agents to utilize our products.”
Already, 20 customers are evaluating agentic EDA capabilities across more than 25 specialized AI agents spanning front-end design, verification, and analog flows.
A parallel shift is taking shape in IP, where revenue climbed 12% sequentially after management confirmed Q1 as the trough. Synopsys is negotiating royalty-based agreements with hyperscalers building custom AI silicon, a model Ghazi calls “factory 2” that layers royalties on top of traditional license fees.
On cost, Ansys integration synergies are only halfway through the committed target, and management has outlined a path to non-GAAP operating margins in the mid-40s, with details set for September’s Investor Day.
Synopsys installed Elliott Investment Management’s Jesse Cohn on an expanded 11-member board through a cooperation agreement announced alongside Q2 earnings.
Reuters reported on July 7 that Synopsys plans to exit its chip fab manufacturing control software business, continuing a pattern of portfolio pruning alongside the pending sale of the Processor IP Solutions unit.
Synopsys stock has dropped 33% from its 52-week high of $652 despite three consecutive guidance raises, weighed down by investor focus on single-digit organic EDA growth and a muted IP recovery that is only now beginning to inflect.
Wall Street Prices SNPS Stock at $564, a 30% Premium to Today’s Close
Of 24 analysts covering Synopsys stock, 16 rate it Buy or Outperform, 6 Hold, and 1 Underperform, with the consensus mean target at $564. That target implies 30% upside from the current $435, with the range spanning $404 to $650 and a $575 median. In July 2025, the stock traded 2% above the consensus target; today it sits 30% below it.
Analysts Expect SNPS EBITDA Margins to Reach 44% by Late Fiscal 2026
Synopsys delivered EBITDA of $950 million on a 42% margin in fiscal Q2, following 44% in Q1 and 38% in Q4 FY25. The Street expects margins to widen again through the second half.
Consensus puts Q3 EBITDA at $1.03 billion (42% margin) and Q4 at $1.12 billion (44% margin), with Q4 running 29% above the year-ago quarter.
Fiscal Q1 2027 estimates reach $1.28 billion on a 49% margin before settling back to $1.04 billion (41%) and $1.13 billion (42%) across Q2 and Q3. Over those four quarters, average EBITDA margins in the consensus sit at 44%, two full points above Q2’s actual 42%.
September’s Investor Day needs to deliver the remaining synergy timeline that bridges today’s 41% operating margin to the mid-40s target management has set.
TIKR’s $792 Target on Synopsys Stock Holds if Integration Gains Sustain Beyond FY26
TIKR’s mid-case model values Synopsys stock at $792 by October 2030, implying 82% total return from the current $435, or 15% annualized over 4.3 years.
That 15% annualized return places Synopsys well above the 10% level typical for established large-cap software, even as the stock sits 33% below its 52-week high and closer to the $376 low.
The $792 target captures the full integrated business compounding over 4+ years. Q2’s margin expansion, sequential IP recovery, three straight guidance raises, and Elliott’s board-level presence all provide early evidence for the operating leverage the model assumes.
With subscription-plus-consumption pricing for AI agents and IP royalties both still pre-revenue, the current consensus may not yet reflect the full earnings power of the combined platform.
Should You Invest in Synopsys, Inc.?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up Synopsys, Inc. stock and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track Synopsys, Inc. alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Access Professional Tools to Analyze SNPS stock on TIKR for Free →
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
